Benzinga | Sep 4, 2020 04:35PM EDT

NYSE American Notifies General Moly About Stockholders' Equity Continued Listing Deficiency

LAKEWOOD, CO / ACCESSWIRE / September 4, 2020 / General Moly, Inc. (the "Company") (NYSE:GMO)(TSX:GMO), the only western-exchange listed, pure-play molybdenum mineral development company, today announced that on August 31, 2020, it received a deficiency letter ("Letter") from the NYSE American stock exchange (the "Exchange") indicating that the Company is below compliance with Section 1003(a)(i) (requiring stockholders' equity of $2.0 million or more if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years), Section 1003(a)(ii) (requiring stockholders' equity of $4.0 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years), and Section 1003(a)(iii) (requiring stockholders' equity of $6.0 million or more if it has reported losses from continuing operations and/or net losses in its five most recent fiscal years) of the NYSE American Company Guide (the "Company Guide"). The Exchange indicated that its review showed that the Company reported a stockholders' deficit as of June 30, 2020 and losses from continuing operations for its five most recent fiscal years ended December 31, 2019.